Report Cards and Feedback for PCCE
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Dec 1, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Primary Care Clinical Excellence (PCCE) Incentive Plan, is being conducted by UCLA Health to improve the quality of primary care services. The goal is to understand what motivates doctors to provide the best care possible, using a performance-based incentive program. This means that doctors will be encouraged to improve their care quality based on specific goals and feedback. The study is a collaboration between the UCLA Health Department of Medicine and the UCLA Anderson School of Management, focusing on how to effectively share information about these quality improvement efforts.
To participate in the trial, doctors must be part of the UCLA Health primary care network and work a minimum of 40% of their time in a clinical role, managing at least 50 patients. However, pediatricians and urgent care physicians are not eligible to participate due to different care guidelines. If doctors join this trial, they can expect to receive feedback on their performance and contribute to a program that aims to enhance primary health care for everyone. This initiative is an important step towards making primary care more effective and patient-centered.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Primary care physicians within the UCLA Health Department of Medicine Primary Care Network that are eligible for the PCCE Incentive program as of October 1, 2023.
- • Physicians with the clinical full-time employee level (FTE) of ≥ 40% as of October 1, 2023
- • Physicians with panel size \>50 patients as of October 1, 2023
- Exclusion criteria:
- • Physicians classified as Pediatrics will be excluded from data analysis given the structural differences in health maintenance guidelines for children.
- • Physicians classified as Urgent Care will be excluded from data analysis given the structural differences in their performance evaluation. They are all in Arm 1.
- • Physicians who participate in the design of this experiment will be excluded from analysis.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Richard Leuchter, MD
Principal Investigator
UCLA Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported